CoverorDie

Squeeze Report — October 14, 2026

Two biotechs with 40%+ short interest — TNGX and CSIQ — frame today's book, but conviction is capped by dilution and cheap borrow. The more interesting tension sits in MMED, where a Medtronic split-off could force a violent, short-lived cover into a float that expands tenfold days later.

15 ranked0 hot (≥80)15 squeezable (≥73)

Today's top short-squeeze candidates

  1. #1BKVBKV Corporation80

    34% of float sold short · 6.1 days to cover · +0% over 20 days

    SI 34%DTC 6.1$24.44+0% 20dEnergy
  2. #2TNGXTango Therapeutics, Inc.78

    41.9% short interest meets ESMO pancreatic cancer data on Oct 23 — real fuel, but a $400M ATM keeps shorts comfortable.

    SI 42%DTC 12.5$22.22-7% 20dHealthcare
  3. #3IEPIcahn Enterprises, L.P. Common78

    Days-to-cover looks extreme at 22, but 51% of a tiny float is only 2.5% of total units — the squeeze math doesn't hold.

    SI 51%DTC 22.4$6.71-4% 20dEnergy
  4. #4REPLReplimune Group, Inc. Common S77

    29% of float sold short · 10.8 days to cover · -7% over 20 days · options pricing in the 93th percentile (crowded)

    SI 29%DTC 10.8$12.11-7% 20dHealthcare
  5. #5ABSIAbsci Corporation Common Stock76

    25% of float sold short · 7.5 days to cover · +15% over 20 days

    SI 25%DTC 7.5$9.10+15% 20dHealthcare
  6. #6SYMSymbotic Inc. Class A Common S76

    Four straight biweekly short increases plus a fresh acquisition, but insider selling and a surviving class action blunt the edge.

    SI 35%DTC 10.1$40.89-4% 20dIndustrials
  7. #7ULCCFrontier Group Holdings, Inc.76

    24% of float sold short · 9.4 days to cover · +0% over 20 days

    SI 24%DTC 9.4$5.58+0% 20dIndustrials
  8. #8IBRXImmunityBio, Inc. Common Stock75

    109% of float sold short · 8.9 days to cover · +20% over 20 days · options pricing in the 87th percentile (crowded)

    SI 109%DTC 8.9$9.80+20% 20dHealthcare
  9. #9TALTAL Education Group75

    40% of float sold short · 6.8 days to cover · +8% over 20 days

    SI 40%DTC 6.8$12.64+8% 20dConsumer Defensive
  10. #10CAKECheesecake Factory Incorporate75

    22% of float sold short · 7.3 days to cover · +16% over 20 days

    SI 22%DTC 7.3$112.37+16% 20dConsumer Cyclical
  11. #11ENOVEnovis Corporation75

    Insider buying and rising shorts are a rare pairing, but near-zero options IV says the market isn't bracing for a squeeze.

    SI 19%DTC 5.8$18.99+6% 20dHealthcare
  12. #12OMEROmeros Corporation Common Stoc75

    FDA-approved YARTEMLEA launch with reimbursement now live, yet shorts are covering, not adding — squeeze mechanics are absent.

    SI 16%DTC 7.0$18.88+10% 20dHealthcare
  13. #13GLOBGLOBANT S.A.75

    31% of float sold short · 13.2 days to cover · -7% over 20 days · options pricing in the 84th percentile (crowded)

    SI 31%DTC 13.2$37.17-7% 20dTechnology
  14. #14TDCTERADATA CORPORATION74

    A $430M remaining buyback limits forced covering; shorts are already exiting at a 6% clip.

    SI 17%DTC 10.5$30.48+4% 20dTechnology
  15. #15NAMSNewAmsterdam Pharma Company N.74

    Shorts added 21.6% into a stock near 52-week lows; a PREVAIL interim read is the only plausible ignition.

    SI 24%DTC 9.4$20.19-5% 20dHealthcare

See the full ranked board

This is the top sliver of 15 names we rank every day. The live board carries rank history, days-to-cover fuel gauges, AI research, and a backtested signal validator.

Open the live squeeze board →